Bio-Techne
TECH
#1659
Rank
A$16.02 B
Marketcap
$101.37
Share price
-0.87%
Change (1 day)
-7.37%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2024 : A$0.61 Billion

According to Bio-Techne's latest financial reports the company's total debt is A$0.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30A$0.68 B45.07%
2022-06-30A$0.47 B-15.36%
2021-06-30A$0.55 B-11.28%
2020-06-30A$0.63 B-12.31%
2019-06-30A$0.71 B57.1%
2018-06-30A$0.45 B2.37%
2017-06-30A$0.44 B250.77%
2016-06-30A$0.12 B27.03%
2015-06-30A$0.10 B630.22%
2014-06-30A$13.74 M
2006-06-30A$18.07 M-5.63%
2005-06-30A$19.15 M-16.57%
2004-06-30A$22.95 M-10.26%
2003-06-30A$25.58 M-20.44%
2002-06-30A$32.15 M-13.09%
2001-06-30A$37 M12.54%
2000-06-30A$32.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$55.14 B 8,837.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.16 B 251.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.29 B 4,647.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.36 B 4,335.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.99 B 385.88%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$30.09 B 4,777.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.1 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA